Nicolas Larmonier
Université de Bordeaux(FR)
Publications by Year
Research Areas
Immune cells in cancer, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology, CAR-T cell therapy research
Most-Cited Works
- → CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative(2004)864 cited
- → Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer(2013)400 cited
- → CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease(2007)278 cited
- → Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis(2012)226 cited
- → Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10(2006)223 cited
- → Immune checkpoint inhibitors and elderly people: A review(2017)196 cited
- → IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity(2021)160 cited
- → Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL− Tumors(2008)159 cited
- → Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells(2014)139 cited
- → Beyond the tumour microenvironment(2019)134 cited